GPCR
Structure Therapeutics Inc.
31.30$
-4.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.3% | 98.3% | 95.1% | 98.3% | 98.7% | 99.1% | |
| 42.2% | 94.7% | 26.7% | 26.9% | 18.8% | 50.5% | |
| 96.7% | 96.5% | 92.8% | 97.0% | 97.8% | 91.3% | |
| 0.7% | 1.6% | 1.3% | – | – | – | |
| 158.1% | 158.2% | 217.7% | 6.0% | 4.3% | 4.3% | |
| 7.9% | 7.8% | 13.3% | 5.1% | 4.0% | 4.0% | |
| 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | |
| 3.9% | 3.1% | 6.1% | 1.0% | 0.9% | 0.9% | |
| -58.1% | -58.2% | -117.7% | 94.0% | 95.7% | 95.7% | |
| -59.3% | -58.2% | -119.5% | -42.9% | -36.4% | -29.7% | |
| 94.5% | 32.9% | 37.4% | 7.6% | 5.8% | 3.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.